MSM人群HIV暴露前预防后淋病与衣原体感染发病率:模型研究
基于美国MSM网络数学模型的HIV、淋球菌和沙眼衣原体传播动力学模拟显示,按CDC指南实施PrEP并扩大覆盖可显著降低STI发病率。参考场景(40%覆盖、40%风险补偿)下,未来十年可避免42%淋球菌和40%衣原体感染;筛查间隔从半年缩短至季度可额外降低50%发病率。
要点
- PrEP相关STI筛查使无症状和直肠STI治疗分别绝对增加17%和16%。
- 风险补偿加倍仍相对无PrEP实现净STI预防。
- 季度筛查较半年筛查可额外降低50%STI发病率。
核心结论
- 实施CDC PrEP指南并扩大PrEP覆盖可显著降低MSM人群STI发病率。
- PrEP设计应视为结合STI筛查的HIV/STI联合预防,而非仅抗病毒药物。
研究设计与样本
- 基于网络的数学建模研究,模拟美国MSM人群中HIV、淋球菌和沙眼衣原体的传播动力学。
- 按CDC指南的处方指征和HIV/STI筛查推荐模拟PrEP uptake,变化PrEP覆盖、风险补偿和STI筛查间隔。
主要发现
- 参考场景(40%覆盖、40%风险补偿)下,未来十年42%的淋球菌感染和40%的衣原体感染将被避免。
- 风险补偿加倍仍相对无PrEP实现净STI预防。
- PrEP相关STI筛查使无症状STI治疗绝对增加17%,直肠STI治疗绝对增加16%。
- 季度筛查与半年筛查相比,STI发病率额外降低50%。
关键数值与推荐
- CDC PrEP指南推荐半年一次STI筛查。
- 参考场景设定PrEP覆盖40%、风险补偿40%。
- 季度筛查较半年筛查额外降低STI发病率50%。
临床怎么用
- 实施CDC PrEP指南并扩大PrEP覆盖以降低MSM人群STI发病率。
- 将PrEP作为结合STI筛查的HIV/STI联合预防措施。
- 考虑缩短STI筛查间隔至季度以进一步降低发病率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Preexposure prophylaxis (PrEP) is highly effective for preventing human immunodeficiency virus (HIV) infection, but risk compensation (RC) in men who have sex with men (MSM) raises concerns about increased sexually transmitted infections (STIs). The Center for Disease Control and Prevention's (CDC's) PrEP guidelines recommend biannual STI screening, which may reduce incidence by treating STIs that would otherwise remain undiagnosed. We investigated these two counteracting phenomena. METHODS: With a network-based mathematical model of HIV, Neisseria gonorrhoeae (NG), and Chlamydia trachomatis (CT) transmission dynamics among MSM in the United States, we simulated PrEP uptake following the prescription indications and HIV/STI screening recommendations in the CDC guidelines. Scenarios varied PrEP coverage (the proportion of MSM indicated for PrEP who received it), RC (a reduction in the per-act probability of condom use), and the STI screening interval. RESULTS: In our reference scenario (40% coverage, 40% RC), 42% of NG and 40% of CT infections would be averted over the next decade. A doubling of RC would still result in net STI prevention relative to no PrEP. STIs declined because PrEP-related STI screening resulted in a 17% and 16% absolute increase in the treatment of asymptomatic and rectal STIs, respectively. Screening and timely treatment at quarterly vs biannual intervals would reduce STI incidence an additional 50%. CONCLUSIONS: Implementation of the CDC PrEP guidelines while scaling up PrEP coverage could result in a significant decline in STI incidence among MSM. Our study highlights the design of PrEP not only as antiretroviral medication but as combination HIV/STI prevention incorporating STI screening.
引用
- Jenness SM, Weiss KM, Goodreau SM, et al. Incidence of Gonorrhea and Chlamydia Following Human Immunodeficiency Virus Preexposure Prophylaxis Among Men Who Have Sex With Men: A Modeling Study. Clin Infect Dis. 2017. PMID: 28505240. doi:10.1093/cid/cix439
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。